The Tidal Therapeutics brand, founded in 2018 (United States), from 2757 sister brands and 17477 competing brands. Tidal Therapeutics is owned by SANOFI, listed on the stock exchange of Paris The International Securities Identification Number (ISIN) of SANOFI is FR0000120578. Tidal Therapeutics belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
SANOFI
(Tidal Therapeutics)
over 5 years*
EUR 104.80